341 related articles for article (PubMed ID: 32562612)
41. Utilization of health care services among Medicare beneficiaries who visit federally qualified health centers.
Lavelle TA; Rose AJ; Timbie JW; Setodji CM; Wensky SG; Giuriceo KD; Friedberg MW; Malsberger R; Kahn KL
BMC Health Serv Res; 2018 Jan; 18(1):41. PubMed ID: 29370837
[TBL] [Abstract][Full Text] [Related]
42. Aggressive Care near the End of Life for Cancer Patients in Medicare Accountable Care Organizations.
Kim H; Keating NL; Perloff JN; Hodgkin D; Liu X; Bishop CE
J Am Geriatr Soc; 2019 May; 67(5):961-968. PubMed ID: 30969439
[TBL] [Abstract][Full Text] [Related]
43. Hospice enrollment among cancer patients in Texas covered by Medicare managed care and traditional fee-for-service plans: a statewide population-based study.
Elting LS; Liao KP; Giordano SH; Guadagnolo BA
Support Care Cancer; 2020 Jul; 28(7):3351-3359. PubMed ID: 31760519
[TBL] [Abstract][Full Text] [Related]
44. Hospice use among Medicare managed care and fee-for-service patients dying with cancer.
McCarthy EP; Burns RB; Ngo-Metzger Q; Davis RB; Phillips RS
JAMA; 2003 May; 289(17):2238-45. PubMed ID: 12734135
[TBL] [Abstract][Full Text] [Related]
45. Disparities in Receipt of Eye Exams Among Medicare Part B Fee-for-Service Beneficiaries with Diabetes - United States, 2017.
Lundeen EA; Wittenborn J; Benoit SR; Saaddine J
MMWR Morb Mortal Wkly Rep; 2019 Nov; 68(45):1020-1023. PubMed ID: 31725705
[TBL] [Abstract][Full Text] [Related]
46. Racial Disparities in Lung Cancer Screening Among Veterans, 2013 to 2021.
Navuluri N; Morrison S; Green CL; Woolson SL; Riley IL; Cox CE; Zullig LL; Shofer S
JAMA Netw Open; 2023 Jun; 6(6):e2318795. PubMed ID: 37326987
[TBL] [Abstract][Full Text] [Related]
47. Racial Disparities in Health Service Utilization Among Medicare Fee-for-Service Beneficiaries Adjusting for Multiple Chronic Conditions.
Gandhi K; Lim E; Davis J; Chen JJ
J Aging Health; 2018 Sep; 30(8):1224-1243. PubMed ID: 28621152
[TBL] [Abstract][Full Text] [Related]
48. Hospital utilization and expenditures among a nationally representative sample of Medicare fee-for-service beneficiaries 2 years after receipt of an Annual Wellness Visit.
Misra A; Lloyd JT
Prev Med; 2019 Dec; 129():105850. PubMed ID: 31629799
[TBL] [Abstract][Full Text] [Related]
49. Correlation Between Ophthalmology Market Saturation and Medicare Utilization Rates.
Berkowitz ST; Liu Y; Chen Q; Patel S
Am J Ophthalmol; 2021 Sep; 229():137-144. PubMed ID: 33910054
[TBL] [Abstract][Full Text] [Related]
50. Evaluating Lung Cancer Screening Across Diverse Healthcare Systems: A Process Model from the Lung PROSPR Consortium.
Rendle KA; Burnett-Hartman AN; Neslund-Dudas C; Greenlee RT; Honda S; Elston Lafata J; Marcus PM; Cooley ME; Vachani A; Meza R; Oshiro C; Simoff MJ; Schnall MD; Beaber EF; Doria-Rose VP; Doubeni CA; Ritzwoller DP
Cancer Prev Res (Phila); 2020 Feb; 13(2):129-136. PubMed ID: 31871221
[TBL] [Abstract][Full Text] [Related]
51. Association of the Comprehensive End-Stage Renal Disease Care Model With Medicare Payments and Quality of Care for Beneficiaries With End-Stage Renal Disease.
Marrufo G; Colligan EM; Negrusa B; Ullman D; Messana J; Shah A; Duvall T; Hirth RA
JAMA Intern Med; 2020 Jun; 180(6):852-860. PubMed ID: 32227133
[TBL] [Abstract][Full Text] [Related]
52. Disability outcomes of older Medicare HMO enrollees and fee-for-service Medicare beneficiaries.
Porell FW; Miltiades HB
J Am Geriatr Soc; 2001 May; 49(5):615-31. PubMed ID: 11380756
[TBL] [Abstract][Full Text] [Related]
53. A sampling strategy for longitudinal and cross-sectional analyses using a large national claims database.
McMurry TL; Lobo JM; Kim S; Kang H; Sohn MW
Front Public Health; 2024; 12():1257163. PubMed ID: 38362210
[TBL] [Abstract][Full Text] [Related]
54. Factors associated with adherence to provider referrals for lung cancer screening with low dose computed tomography before and during COVID-19 pandemic.
Li J; Stults CD; Liang SY; Martinez M
BMC Cancer; 2023 Aug; 23(1):809. PubMed ID: 37644406
[TBL] [Abstract][Full Text] [Related]
55. Black Race Remains Associated with Lower Eligibility for Screening Using 2021 US Preventive Services Task Force Recommendations Among Lung Cancer Patients at an Urban Safety Net Hospital.
Liu A; Siddiqi N; Tapan U; Mak KS; Steiling KA; Suzuki K
J Racial Ethn Health Disparities; 2023 Dec; 10(6):2836-2843. PubMed ID: 36441493
[TBL] [Abstract][Full Text] [Related]
56. The "Welcome to Medicare" visit: a missed opportunity for cancer screening among women?
Salloum RG; Jensen GA; Biddle AK
J Womens Health (Larchmt); 2013 Jan; 22(1):19-25. PubMed ID: 23145890
[TBL] [Abstract][Full Text] [Related]
57. Considerations to increase rates of breast cancer screening across populations.
Patt D; Gordan L; Patel K; Okon T; Ferreyros N; Markward N; Sullivan M; Burnett B; Getachew B; Harris C
Am J Manag Care; 2022 Apr; 28(3 Spec. No.):SP136-SP138. PubMed ID: 35285592
[TBL] [Abstract][Full Text] [Related]
58. Augmented meaningful use criteria to identify patients eligible for lung cancer screening.
Raz DJ; Dunham R; Tiep B; Sandoval A; Grannis F; Rotter A; Kim JY
Ann Thorac Surg; 2014 Sep; 98(3):996-1002. PubMed ID: 25063304
[TBL] [Abstract][Full Text] [Related]
59. Medicare HMOs: who joins and who leaves?
Virnig BA; Morgan RO; DeVito CA; Persily NA
Am J Manag Care; 1998 Apr; 4(4):511-8. PubMed ID: 10179910
[TBL] [Abstract][Full Text] [Related]
60. Racial Differences in Adherence to Lung Cancer Screening Follow-up: A Systematic Review and Meta-analysis.
Kunitomo Y; Bade B; Gunderson CG; Akgün KM; Brackett A; Cain H; Tanoue L; Bastian LA
Chest; 2022 Jan; 161(1):266-275. PubMed ID: 34390706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
